Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-24-091966
Filing Date
2024-10-30
Accepted
2024-10-30 08:31:15
Documents
15

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea021895001-424b4_polyrizon.htm 424B4 3355936
2 GRAPHIC image_001.jpg GRAPHIC 8028
3 GRAPHIC image_002.jpg GRAPHIC 33181
4 GRAPHIC image_003.jpg GRAPHIC 21503
5 GRAPHIC image_004.jpg GRAPHIC 15242
6 GRAPHIC image_005.jpg GRAPHIC 12234
7 GRAPHIC image_006.jpg GRAPHIC 11284
8 GRAPHIC image_007.jpg GRAPHIC 17275
9 GRAPHIC image_008.jpg GRAPHIC 14622
10 GRAPHIC image_009.jpg GRAPHIC 12496
11 GRAPHIC image_010.jpg GRAPHIC 11681
12 GRAPHIC image_011.jpg GRAPHIC 14144
13 GRAPHIC image_012.jpg GRAPHIC 24177
14 GRAPHIC image_013.jpg GRAPHIC 38864
15 GRAPHIC image_014.jpg GRAPHIC 8490
  Complete submission text file 0001213900-24-091966.txt   3693767
Mailing Address 12/6 BOROCHOV ST. RAANANA IL 4343306
Business Address 12/6 BOROCHOV ST. RAANANA IL 4343306 972-54-7979668
Polyrizon Ltd. (Filer) CIK: 0001893645 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-266745 | Film No.: 241407543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)